Mj. Garcia et al., PREDICTIVE PERFORMANCE OF 2 PHENYTOIN PHARMACOKINETIC DOSING PROGRAMSFROM NONSTEADY STATE DATA, Therapeutic drug monitoring, 16(4), 1994, pp. 380-387
The present work evaluated the performance of two computer programs: D
rugcalc, which utilizes the bayesian (method 1) approach and PKS, whic
h can utilize both the non-bayesian (method 2) and bayesian (method 3)
approaches. Both programs permit the introduction of serum level data
obtained in both situations: steady-state and nonsteady-state. The pr
ediction of phenytoin concentrations (n = 771) were made from steady-s
tate (n = 378) and nonsteady-state (n = 175), and combined steady-stat
e and nonsteady-state (n = 218) concentrations. The observed serum con
centrations (at least two nonsteady-state and two steady-state per pat
ient) were collected under routine clinical conditions in 15 patients
receiving this drug. The main contribution to prediction errors is att
ributed to the difference between doses corresponding to the predicted
and feedback serum concentrations, dD, in such a way that when the er
rors obtained for dD greater-than-or-equal-to 100 mg/day are excluded,
the predictive performance increases significantly for all methods. I
n this sense, increases in precision were 87, 64, and 66% for methods
1, 2, and 3, respectively. Moreover, when dD <100 mg/day, nonsteady-st
ate feedback concentrations (less-than-or-equal-to 3) only afforded cl
inically acceptable predictions (ME +/- SD <3 mg/L) when they were com
bined with at least one steady-state datum value, and the bayesian app
roach was used. Despite this, for all the methods analyzed, nonsteady-
state data are seen to be useful for detecting situations of potential
toxicity in a significant proportion of cases (71.4-84.6%) and, when
method 3 is used, may offer useful information for the adjustment of d
osage schedules.